Biomedicines 10, 1248
While this situation commonly would drive payers to sharply constrain access through onerous prior authorization rules, restrictions data suggest that many commercial payers are allowing use of Wegovy by patients meeting the BMI requirements if they have either failed on previous treatment or have taken part in a weight management program
Fogelson N, Kogan E, Korczyn AD, Giladi N, Shabtai H, Neufeld MY (2003) Effects of rivastigmine on the quantitative EEG in demented Parkinsonian patients
3 Pharma companies are redefining partnerships with digital health players to control access, pricing, and patient pathways
Orders intended for resale, distribution, or institutional supply are not processed
Choosing fiber sources that are less likely to cause gas or bloating may improve comfort over time